These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16761241)

  • 1. Effects of antiglaucoma drugs GLC756, a novel dopamine D2 agonist and D1 antagonist, and timolol on endotoxin-induced TNF-alpha release in serum of rats.
    Laengle UW; Markstein R; Schneider V; Roman D
    Eur J Ophthalmol; 2006; 16(3):401-6. PubMed ID: 16761241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
    Laengle UW; Markstein R; Schneider V; Greiner B; Roman D
    Exp Eye Res; 2005 Jun; 80(6):847-52. PubMed ID: 15939041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced-uveitis and -arthritis in rats.
    Laengle UW; Court M; Markstein R; Germann PG; Nogues V; Roman D
    Exp Toxicol Pathol; 2005 Nov; 57(2):127-34. PubMed ID: 16325523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
    Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
    Exp Eye Res; 2006 Dec; 83(6):1335-9. PubMed ID: 16965772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells.
    Laengle UW; Markstein R; Cazaubon C; Roman D
    Jpn J Ophthalmol; 2009 Mar; 53(2):159-163. PubMed ID: 19333701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
    Laengle UW; Trendelenburg AU; Markstein R; Nogues V; Provencher-Bollinger A; Roman D
    Exp Eye Res; 2006 Nov; 83(5):1246-51. PubMed ID: 16938291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
    Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
    Clin Exp Ophthalmol; 2007; 35(7):645-50. PubMed ID: 17894685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts.
    Laengle UW; Markstein R; Pralet D; Greiner B; Roman D
    Eur J Ophthalmol; 2006; 16(1):67-72. PubMed ID: 16496248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis.
    Ohgami K; Ilieva I; Shiratori K; Koyama Y; Jin XH; Yoshida K; Kase S; Kitaichi N; Suzuki Y; Tanaka T; Ohno S
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):275-81. PubMed ID: 15623784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system.
    Mastronardi CA; Yu WH; McCann S
    Neuroimmunomodulation; 2001; 9(3):148-56. PubMed ID: 11752888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13.
    Marie O; Thillaye-Goldenberg B; Naud MC; de Kozak Y
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2275-82. PubMed ID: 10476793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.
    Ulich TR; Guo KZ; Irwin B; Remick DG; Davatelis GN
    Am J Pathol; 1990 Nov; 137(5):1173-85. PubMed ID: 2240164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats.
    Lin Y; Zhu X; Yao WZ; Yang YL; A LT; Chen L
    Chin Med J (Engl); 2011 Apr; 124(7):1069-74. PubMed ID: 21542970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma.
    Prünte C; Flammer J
    Ophthalmology; 1995 Sep; 102(9):1291-7. PubMed ID: 9097765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice.
    Haskó G; Szabó C; Merkel K; Bencsics A; Zingarelli B; Kvetan V; Vizi ES
    Immunol Lett; 1996 Mar; 49(3):143-7. PubMed ID: 8739308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo.
    Ohgami K; Shiratori K; Kotake S; Nishida T; Mizuki N; Yazawa K; Ohno S
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2694-701. PubMed ID: 12766075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats.
    Suzuki J; Manola A; Murakami Y; Morizane Y; Takeuchi K; Kayama M; Miller JW; Sobrin L; Vavvas DG
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6565-71. PubMed ID: 21775660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN; Abraini JH
    Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage.
    Metoki T; Ohguro H; Ohguro I; Mamiya K; Ito T; Nakazawa M
    Jpn J Ophthalmol; 2005; 49(6):453-461. PubMed ID: 16365790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunoglobulin preparations for intravenous use prevent endotoxin-induced uveitis in rats.
    Obrador E; Peinado E; de Kozak Y; Ruiz-Moreno JM; Alio JL
    Ophthalmic Res; 1999; 31(1):59-67. PubMed ID: 9831824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.